Clinical Trial

The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans

Study acronym: PTSD
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to develop a new behavioral treatment for U.S. combat veterans with post-traumatic stress disorder (PTSD), very brief exposure to combat-related stimuli. The main questions it aims to answer are: 1. How does Very Brief Exposure (combat images and control everyday images) and Visible Exposure to combat stimuli affect brain activity and subjective fear ratings? 2. To what extent are participants aware of the stimuli presented and tolerating the exposures? All participants will view both very brief exposure and visible exposure to combat stimuli in the functional magnetic brain imaging (fMRI) scan. They will provide ratings of fear, awareness, and tolerability. Researchers will compare U.S. combat veterans with PTSD and healthy controls to confirm differences in brain region activation and ratings.
Protocol Amendment History 2 changes
notable Enrollment increased: 80 -> 90 participants 2026-07-30
notable Primary completion pushed: 2026-07 -> 2026-12 2026-07-30
Trial Details
NCT Number NCT06218381
Lead Sponsor Children's Hospital Los Angeles
Conditions Post Traumatic Stress Disorder
Enrollment 90 participants
Start Date 2024-03-22
Primary Completion 2026-12 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-29